Suppr超能文献

抑制极光激酶A通过诱导宫颈癌细胞的细胞周期阻滞和凋亡来促进化学敏感性。

Inhibition of Aurora A promotes chemosensitivity via inducing cell cycle arrest and apoptosis in cervical cancer cells.

作者信息

Sun Jian-Ming, Yang Li-Na, Xu Han, Chang Bin, Wang Hua-Ying, Yang Gong

机构信息

Cancer Institute, Fudan University Shanghai Cancer Center Shanghai 200032, China ; Department of Gynecological Oncology, Fudan University Shanghai Cancer Center Shanghai 200032, China ; Department of Oncology, Shanghai Medical College, Fudan University Shanghai 200032, China ; Department of Obstetrics and Gynecology, Putuo Hospital, Shanghai University of Traditional Chinese Medicine Shanghai 200062, China.

Cancer Institute, Fudan University Shanghai Cancer Center Shanghai 200032, China ; Department of Oncology, Shanghai Medical College, Fudan University Shanghai 200032, China.

出版信息

Am J Cancer Res. 2015 Feb 15;5(3):1133-45. eCollection 2015.

Abstract

Aurora kinase A (AurA) regulates genomic instability and tumorigenesis in multiple cancer types. Although some studies have reported that Aur A may predict cervical cancer outcomes, its precise function and molecular mechanism in cervical cancer pathogenesis remain unclear. In this study, by overexpression or silencing of Aur A in cervical cancer cell lines, we found that overexpression of Aur A promoted cell proliferation through G1/S cell cycle transition and anti-apoptosis, xenograft tumor growth and chemoresistance to Taxol. We further found that inhibition of Aur A with its specific inhibitor VX-680 enhanced the antitumor effect of Taxol via inducing apoptosis. Moreover, the clinical analysis from tissue samples demonstrated that Aur A was overexpressed, and the expression of Aur A and pERK1/2 was negatively correlated in cervical cancer tissues. The above results may provide some potential insights in treatment of cervical cancer in clinic.

摘要

极光激酶A(AurA)在多种癌症类型中调节基因组不稳定性和肿瘤发生。尽管一些研究报道AurA可能预测宫颈癌的预后,但其在宫颈癌发病机制中的精确功能和分子机制仍不清楚。在本研究中,通过在宫颈癌细胞系中过表达或沉默AurA,我们发现AurA的过表达通过G1/S细胞周期转换和抗凋亡促进细胞增殖、异种移植肿瘤生长以及对紫杉醇的化疗耐药。我们进一步发现,用其特异性抑制剂VX-680抑制AurA可通过诱导凋亡增强紫杉醇的抗肿瘤作用。此外,来自组织样本的临床分析表明,AurA在宫颈癌组织中过表达,且AurA与pERK1/2的表达在宫颈癌组织中呈负相关。上述结果可能为临床治疗宫颈癌提供一些潜在的见解。

相似文献

引用本文的文献

8
Potential new biomarkers for squamous carcinoma of the uterine cervix.子宫颈鳞状细胞癌潜在的新型生物标志物。
ESMO Open. 2018 Jun 28;3(4):e000352. doi: 10.1136/esmoopen-2018-000352. eCollection 2018.

本文引用的文献

2
Developments in the systemic treatment of metastatic cervical cancer.转移性宫颈癌的系统治疗进展。
Cancer Treat Rev. 2013 Aug;39(5):430-43. doi: 10.1016/j.ctrv.2012.05.009. Epub 2012 Jun 22.
4
Worldwide burden of cervical cancer in 2008.2008 年全球宫颈癌负担。
Ann Oncol. 2011 Dec;22(12):2675-2686. doi: 10.1093/annonc/mdr015. Epub 2011 Apr 6.
5
Stanniocalcin 1 and ovarian tumorigenesis.斯钙素 1 与卵巢肿瘤发生。
J Natl Cancer Inst. 2010 Jun 2;102(11):812-27. doi: 10.1093/jnci/djq127. Epub 2010 May 18.
8
Aurora kinase inhibitors--rising stars in cancer therapeutics?极光激酶抑制剂——癌症治疗领域的后起之秀?
Mol Cancer Ther. 2010 Feb;9(2):268-78. doi: 10.1158/1535-7163.MCT-09-0765. Epub 2010 Feb 2.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验